477 related articles for article (PubMed ID: 21972097)
1. De- and remyelination in the CNS white and grey matter induced by cuprizone: the old, the new, and the unexpected.
Skripuletz T; Gudi V; Hackstette D; Stangel M
Histol Histopathol; 2011 Dec; 26(12):1585-97. PubMed ID: 21972097
[TBL] [Abstract][Full Text] [Related]
2. rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination.
Mullin AP; Cui C; Wang Y; Wang J; Troy E; Caggiano AO; Parry TJ; Colburn RW; Pavlopoulos E
Neurobiol Dis; 2017 Sep; 105():142-155. PubMed ID: 28576706
[TBL] [Abstract][Full Text] [Related]
3. The Cannabinoid CB1/CB2 Agonist WIN55212.2 Promotes Oligodendrocyte Differentiation In Vitro and Neuroprotection During the Cuprizone-Induced Central Nervous System Demyelination.
Tomas-Roig J; Wirths O; Salinas-Riester G; Havemann-Reinecke U
CNS Neurosci Ther; 2016 May; 22(5):387-95. PubMed ID: 26842941
[TBL] [Abstract][Full Text] [Related]
4. Diffusion kurtosis imaging probes cortical alterations and white matter pathology following cuprizone induced demyelination and spontaneous remyelination.
Guglielmetti C; Veraart J; Roelant E; Mai Z; Daans J; Van Audekerke J; Naeyaert M; Vanhoutte G; Delgado Y Palacios R; Praet J; Fieremans E; Ponsaerts P; Sijbers J; Van der Linden A; Verhoye M
Neuroimage; 2016 Jan; 125():363-377. PubMed ID: 26525654
[TBL] [Abstract][Full Text] [Related]
5. Selective ultrastructural vulnerability in the cuprizone-induced experimental demyelination.
Acs P; Komoly S
Ideggyogy Sz; 2012 Jul; 65(7-8):266-70. PubMed ID: 23074847
[TBL] [Abstract][Full Text] [Related]
6. Regional differences between grey and white matter in cuprizone induced demyelination.
Gudi V; Moharregh-Khiabani D; Skripuletz T; Koutsoudaki PN; Kotsiari A; Skuljec J; Trebst C; Stangel M
Brain Res; 2009 Aug; 1283():127-38. PubMed ID: 19524552
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Stereotactic Injections on Demyelination and Remyelination: a Study in the Cuprizone Model.
Tejedor LS; Wostradowski T; Gingele S; Skripuletz T; Gudi V; Stangel M
J Mol Neurosci; 2017 Apr; 61(4):479-488. PubMed ID: 28124770
[TBL] [Abstract][Full Text] [Related]
8. The cuprizone model: regional heterogeneity of pathology.
Wergeland S; Torkildsen Ø; Myhr KM; Mørk SJ; Bø L
APMIS; 2012 Aug; 120(8):648-57. PubMed ID: 22779688
[TBL] [Abstract][Full Text] [Related]
9. Distribution of oligodendrocyte loss and mitochondrial toxicity in the cuprizone-induced experimental demyelination model.
Acs P; Selak MA; Komoly S; Kalman B
J Neuroimmunol; 2013 Sep; 262(1-2):128-31. PubMed ID: 23890807
[TBL] [Abstract][Full Text] [Related]
10. Thyroid hormone alleviates demyelination induced by cuprizone through its role in remyelination during the remission period.
Zhang M; Zhan XL; Ma ZY; Chen XS; Cai QY; Yao ZX
Exp Biol Med (Maywood); 2015 Sep; 240(9):1183-96. PubMed ID: 25577802
[TBL] [Abstract][Full Text] [Related]
11. Ferroptosis Mediates Cuprizone-Induced Loss of Oligodendrocytes and Demyelination.
Jhelum P; Santos-Nogueira E; Teo W; Haumont A; Lenoël I; Stys PK; David S
J Neurosci; 2020 Nov; 40(48):9327-9341. PubMed ID: 33106352
[TBL] [Abstract][Full Text] [Related]
12. Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication.
Steelman AJ; Thompson JP; Li J
Neurosci Res; 2012 Jan; 72(1):32-42. PubMed ID: 22015947
[TBL] [Abstract][Full Text] [Related]
13. Minocycline reduces remyelination by suppressing ciliary neurotrophic factor expression after cuprizone-induced demyelination.
Tanaka T; Murakami K; Bando Y; Yoshida S
J Neurochem; 2013 Oct; 127(2):259-70. PubMed ID: 23647102
[TBL] [Abstract][Full Text] [Related]
14. A novel flavanone derivative ameliorates cuprizone-induced behavioral changes and white matter pathology in the brain of mice.
Sun ZY; Gu HS; Chen X; Zhang L; Li XM; Zhang JW; Li L
Psychiatry Res; 2017 Nov; 257():249-259. PubMed ID: 28783571
[TBL] [Abstract][Full Text] [Related]
15. Cuprizone-Dependent De/Remyelination Responses and Functional Correlates in Mouse Strains Adopted to Model Relapsing, Chronic and Progressive Experimental Autoimmune Encephalomyelitis.
Buonvicino D; Ranieri G; Chiarugi A
Neurotox Res; 2021 Jun; 39(3):658-666. PubMed ID: 33475965
[TBL] [Abstract][Full Text] [Related]
16. Cuprizone effect on myelination, astrogliosis and microglia attraction in the mouse basal ganglia.
Pott F; Gingele S; Clarner T; Dang J; Baumgartner W; Beyer C; Kipp M
Brain Res; 2009 Dec; 1305():137-49. PubMed ID: 19799876
[TBL] [Abstract][Full Text] [Related]
17. G-Protein-Coupled Receptor Gpr17 Expression in Two Multiple Sclerosis Remyelination Models.
Nyamoya S; Leopold P; Becker B; Beyer C; Hustadt F; Schmitz C; Michel A; Kipp M
Mol Neurobiol; 2019 Feb; 56(2):1109-1123. PubMed ID: 29873041
[TBL] [Abstract][Full Text] [Related]
18. Cuprizone-induced demyelination in the rat cerebral cortex and thyroid hormone effects on cortical remyelination.
Silvestroff L; Bartucci S; Pasquini J; Franco P
Exp Neurol; 2012 May; 235(1):357-67. PubMed ID: 22421533
[TBL] [Abstract][Full Text] [Related]
19. Restoration of FcRgamma/Fyn signaling repairs central nervous system demyelination.
Seiwa C; Yamamoto M; Tanaka K; Fukutake M; Ueki T; Takeda S; Sakai R; Ishige A; Watanabe K; Akita M; Yagi T; Tanaka K; Asou H
J Neurosci Res; 2007 Apr; 85(5):954-66. PubMed ID: 17290413
[TBL] [Abstract][Full Text] [Related]
20. Cuprizone induces similar demyelination in male and female C57BL/6 mice and results in disruption of the estrous cycle.
Taylor LC; Gilmore W; Ting JP; Matsushima GK
J Neurosci Res; 2010 Feb; 88(2):391-402. PubMed ID: 19746424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
